# Paulson Warns Against a United States and China Break as Beijing's Biotech Pushes Outward

A former United States Treasury secretary says distrust now poses a greater risk than trade imbalances, even as Chinese firms call their global expansion irreversible.

- Published: 2026-06-11T11:56:36.051Z
- Canonical: https://polylog.news/2026-06-11/paulson-warns-against-a-united-states-and-china-break-as-bei
- Publisher: Polylog (Global desk)
- Section: geopolitics
- Sources: [South China Morning Post (Diplomacy)](https://www.scmp.com/news/china/diplomacy/article/3356720/do-not-let-us-china-ties-spiral-out-control-ex-treasury-chief-paulson-warns?utm_source=rss_feed), [South China Morning Post (Business)](https://www.scmp.com/business/china-business/article/3356778/chinas-biotech-industry-sees-global-expansion-unstoppable-despite-us-pressure?utm_source=rss_feed)

Henry Paulson, the former United States Treasury secretary, urged Washington and Beijing to manage their strategic competition before it widens into broader conflict. The [South China Morning Post](https://www.scmp.com/news/china/diplomacy/article/3356720/do-not-let-us-china-ties-spiral-out-control-ex-treasury-chief-paulson-warns?utm_source=rss_feed) reported that Paulson sees deepening distrust, rather than trade imbalances, as the greater danger to the relationship between the world's two largest economies.

His warning arrives as the commercial split keeps widening. The same newspaper [reported](https://www.scmp.com/business/china-business/article/3356778/chinas-biotech-industry-sees-global-expansion-unstoppable-despite-us-pressure?utm_source=rss_feed) that Chinese biotechnology firms are pressing ahead with global expansion that industry insiders call irreversible, even as Washington rolls out investment restrictions and national-security measures intended to slow their advance.

Both accounts come from a Hong Kong outlet and reflect a view from the Chinese side of the divide. Read together, they describe a decoupling that policy is accelerating rather than preventing. Each new United States restriction pushes Chinese firms to build supply chains, capital sources and markets that route around the United States, which is the structural shift investors should track.

## What this means

The United States and China decoupling is moving from tariffs into capital and technology, and the response from Chinese industry is to globalize faster rather than retreat. For investors, the relevant question is no longer whether the two economies separate, but how quickly parallel systems in finance and technology take shape.

## What to watch

- New United States entity-list designations or investment curbs aimed at Chinese firms.
- Where Chinese biotech and technology companies raise capital and list shares as United States access narrows.
- Any high-level United States and China talks aimed at stabilizing the relationship.